drug testing

Horse Sales And HISA, The Overlap

With the Horseracing Integrity and Safety Integrity Act's (HISA) anti-doping and medication control program set for launch Monday--pending approval by the Federal Trade Commission (FTC)--the inevitable focus will be on the spider web of post-race and out-of-competition testing set to blanket most of the nation. But with it has come this other question: What do buyers now need to be aware of when purchasing a horse at the sales or privately? The question has gained added currency since a recent presentation before the Southern California horsemen by representatives from the...

[ Read More ]
HIWU's Scollay: New Medication Rules 'Your New Bible'

Despite all the legal jockeying these past few weeks and months, the Horseracing Integrity and Safety Act's (HISA) anti-doping and medication control program still appears set for launch on Jan. 1 in the vast majority of states that conduct pari-mutuel wagering. This means on the first day of 2023, thousands of trainers, veterinarians and other backstretch workers must grapple with a new set of rules guiding how and when to administer a set of everyday medications--the list of which can be found here--to avoid falling foul of a post-race and...

[ Read More ]
Hardy Named Executive Director of RMTC

Dr. Michael Hardy has been hired as its next Executive Director of the Racing Medication & Testing Consortium. In his new role, Dr. Hardy will be responsible for the management of the RMTC's Laboratory Accreditation and External Quality Assurance Program in conjunction with the new Horseracing Integrity and Welfare Unit. He will also be charged with the administration of the RMTC's Scientific Advisory Committee process, the monitoring of emerging threats to the integrity of racing and the health and welfare of racehorses, administrative oversight of RMTC-funded research projects, and coordinating...

[ Read More ]
Lazarus on HISA Anti-Doping and Medication Control

Bit by bit, the pieces of the puzzle are slotting into place for the Anti-Doping and Medication Control (ADMC) component of the Horseracing Integrity and Safety Act, set to go into effect at the start of next year. Last month, that program was designated an agency to officially run it--namely Drug Free Sports International, an organization that has helped administer drug testing programs to a slew of major human sports leagues. Then, last week, the draft ADMC rules were for put out public comment. These draft rules can be found...

[ Read More ]
HISA Draft Rules Augur Fundamental Changes For Industry

Draft rules for the Horseracing Integrity and Safety Act (HISA) were unveiled Thursday morning, auguring fundamental shifts to the way the industry is policed, including a markedly more stringent approach to medication violation penalties. Far from concrete, these draft rules are subject to the red pen. Nevertheless, as currently written, they raise notable differences to the working status quo. Broadly, the draft rules take a binary approach to drug testing, breaking medications down into primary and secondary categories. A primary substance is one that is always prohibited, while a secondary...

[ Read More ]
Maryland THA Issues Warning on Adjunct Bleeder Medication

The Maryland Thoroughbred Horsemen's Association issued the following statement to its members Tuesday: "Effective immediately, horsemen are urged to discontinue the use of any and all adjunct bleeder medications for horses in training, including in particular, aminocaproic acid--commonly called Amicar. Amicar and several other adjunct bleeder medications were placed on the Prohibited List in 2013 under the Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Code and the National Uniform Medication Program. Aminocaproic acid, for example is a Class 4 substance and penalty...

[ Read More ]
CBD: Should It be Used on the Backstretch?

In March of 2018 when the ground around Ontario was frozen solid as a rock, Warren Byrne took a nasty spill. He had just hopped on a hot-headed unraced 3-year-old gelding when it took off blindly. Byrne was pitched onto the hard ground, breaking his upper arm--an extensive fracture that required a plate and seven screws. After the surgery, doctors warned Byrne that he was suffering bone-density issues from a medication he had long taken, describing the problem as being akin to early osteoporosis. He also reacted badly to the...

[ Read More ]
Q&A: Mary Scollay on Drug Testing Protocols & Baffert Otomax Explanation

Since Sunday morning, horse racing has largely been a one-issue sport. That morning, of course, trainer Bob Baffert announced that GI Kentucky Derby winner Medina Spirit (Protonico) had tested positive for 21 picograms per milliliter of betamethasone in a post-race sample. Betamethasone is a regulated corticosteroid commonly used in horse racing as an intra-articular joint injection. In Kentucky as of last year, a detection of betamethasone at any level is deemed a violation. The previous threshold was 10 picograms per milliliter. A split sample will now go for confirmation testing....

[ Read More ]
TIF: How Will Racing Pay for HISA? Grow the Business!

by Thoroughbred Idea Foundation The creation of the Horseracing Integrity and Safety Authority (HISA) is the most significant development in American racing at the federal level since the passage of the Interstate Horseracing Act in 1978. Questions now being rightly considered include how much HISA will cost and where will its funding originate from. Below, we offer some perspective on the costs. But as the greater industry determines where the funding will come from over time, racing should proactively adopt policies which seek to grow the wagering business. The industry...

[ Read More ]
New York Advances Clenbuterol Restrictions
New York Advances Clenbuterol Restrictions

The New York clenbuterol clampdown that was foreshadowed earlier this month by New York State Gaming Commission (NYSGC) equine medical director Scott Palmer, VMD, has been codified into a series of proposed rule amendments that advanced Nov. 30 by a unanimous 5-0 commission vote. The new clenbuterol regulations follow a model rule of the Racing Medication and Testing Consortium (RMTC) that was approved last August. After publication in the New York State Register and a public commentary period, the commission will have to vote again to formally adopt the changes....

[ Read More ]
Delaware Thoroughbred Racing Commission Comes Out Against HISA

Citing lack of financial information outlined in its framework, the Delaware Thoroughbred Racing Commission (DTRC) unanimously voted Oct. 14 to oppose U.S. Senate Bill 4547, the Horseracing Integrity and Safety Act. The U.S. House of Representatives passed its version (HR 1754) Sept. 29 by a voice vote. The Delaware Harness Racing Commission (DHRC) has also come out in opposition of the pending legislation, claiming the bill is an "unnecessary burden that could be potentially harmful to the entire horseracing industry." According to a release, the DTHC claims that unknown costs...

[ Read More ]
Keeneland, Fasig-Tipton Announce New Restrictions On Drugs, Including Clenbuterol

Keeneland and Fasig-Tipton are instating new restrictions on the use of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids and bronchodilators, including Clenbuterol, for all horses sold at sales conducted by the two major Thoroughbred auction houses effective immediately, officials from Keeneland and Fasig-Tipton announced Thursday. These latest reforms are in addition to restrictions put in place earlier this year for 2-year-old sales held at Keeneland and Fasig-Tipton, and follow action in 2009 to ban the use of anabolic steroids in sales horses and last year's ban on the off-label use of bisphosphonates...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.